Allogene Therapeutics
ALLO
#7148
Rank
A$0.62 B
Marketcap
$2.99
Share price
1.63%
Change (1 day)
-33.51%
Change (1 year)

Allogene Therapeutics (ALLO) - Cash on Hand

Cash on Hand as of September 2024 : A$0.46 Billion

According to Allogene Therapeutics 's latest financial reports the company has A$0.46 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Allogene Therapeutics - Cash on Hand chart (from 2018 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31A$0.76 B20.52%
2021-12-31A$0.63 B-41.42%
2020-12-31A$1.07 B42.09%
2019-12-31A$0.75 B16.2%
2018-12-31A$0.65 B
2017-12-31N/A

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$0.43 B-6.58%๐Ÿ‡บ๐Ÿ‡ธ USA